CD209 Genetic Polymorphism and Tuberculosis Disease
Author Information
Author(s): Vannberg Fredrik O., Chapman Stephen J., Khor Chiea C., Tosh Kerrie, Floyd Sian, Jackson-Sillah Dolly, Crampin Amelia, Sichali Lifted, Bah Boubacar, Gustafson Per, Aaby Peter, McAdam Keith P. W. J., Bah-Sow Oumou, Lienhardt Christian, Sirugo Giorgio, Fine Paul, Hill Adrian V. S.
Primary Institution: Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom
Hypothesis
The study investigates the role of the CD209 -336A/G variant in susceptibility to tuberculosis in a large sample of individuals from sub-Saharan Africa.
Conclusion
The CD209 -336G variant allele is associated with significant protection against tuberculosis in individuals from sub-Saharan Africa.
Supporting Evidence
- The -336G allele was significantly under-represented in tuberculosis cases compared to healthy controls.
- Patients with the -336GG genotype were associated with a decreased risk of cavitary tuberculosis.
- The study included a large sample size of 2,176 individuals from multiple countries.
Takeaway
Some people have a gene that helps protect them from getting tuberculosis, especially in Africa.
Methodology
Genotyping of the CD209 -336A/G SNP was performed in tuberculosis case-control studies from four sub-Saharan African countries.
Potential Biases
Potential confounding factors such as HIV status were considered but may still influence results.
Limitations
The study may not be generalizable to populations outside sub-Saharan Africa.
Participant Demographics
Participants were individuals from four sub-Saharan African countries, including The Gambia, Republic of Guinea, Guinea-Bissau, and Malawi.
Statistical Information
P-Value
0.006
Confidence Interval
0.77–0.96
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website